C2i Genomics

📍 New York, United States👥 61 employees💰 Last funded Mar 2021
C2i Genomics is the first company to develop the most comprehensive whole-genome monitoring of cancer recurrence and progression by analyzing subtle changes in the pattern of the tumor’s DNA.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
Founded
Investor geography2 countries
United States
1
Singapore
1
Frequently asked questions
Who invested in C2i Genomics?
C2i Genomics has 2 investors on record on gritt.io.
When did C2i Genomics last raise funding?
The most recent investment in C2i Genomics recorded on gritt.io was in March 2021.
What industry is C2i Genomics in?
C2i Genomics operates in Wellness and Fitness Services. Find similar Wellness and Fitness Services investors on gritt.io.
Where is C2i Genomics based?
C2i Genomics is headquartered in New York, United States.